Certified by Founder Lodge
Alta Partners
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $20,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alta Partners is a leading healthcare venture capital firm, partnering with pioneers in the industry since 1996. Trust, focus, and impact are key tenets of our culture. Trust keeps us accoun
| Company | Date | Round | Raised |
|---|---|---|---|
Free Market Health |
November, 02 ,2023 | Unknown | $20,000,000 |
eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
Lassen Therapeutics |
December, 21 ,2023 | Series B | $85,000,000 |
Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
Harbor Health |
January, 12 ,2024 | Unknown | $95,500,000 |
Edgewood Oncology |
March, 26 ,2024 | Series A | $20,000,000 |
eGenesis, Inc. |
September, 04 ,2024 | Series B | $191,000,000 |
Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
Free Market Health
eGenesis, Inc.
Lassen Therapeutics
Be Biopharma
Harbor Health
Edgewood Oncology
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Formulary Financial | $4,600,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)